Download PDF
1 / Pages

Other users also viewed these articles

Mechanisms and therapeutic targets of mitochondria in the progression of metabolic dysfunction-associated steatotic liver disease Chenyang Mu; Sijie Wang; Zenghan Wang; Jian Tan; Haozan Yin; Yuefan Wang; Zhihui Dai; Dongyang Ding; Fu Yang;
10.1016/j.aohep.2024.101774
Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study Samantha Thifani Alrutz Barcelos; Amanda Souza Silva-Sperb; Helena Abadie Moraes; Larisse Longo; Bruna Concheski de Moura; Matheus Truccolo Michalczuk; Carolina Uribe-Cruz; Carlos Thadeu Schmidt Cerski; Themis Reverbel da Silveira; Valesca Dall'Alba; Mário Reis Álvares-da-Silva;
Ann Hepatol. 2023;28:
NAFLD: Challenges and opportunities to address the public health challenge in Latin America Juan Pablo Arab; Luis Antonio Díaz; Melisa Dirchwolf; Henry Mark; Jeffrey V. Lazarus; Elly Vaughan; Nahum Méndez-Sánchez; Claudia P. de Oliveira; Adrián Gadano; Marco Arrese;
10.1016/j.aohep.2021.100359